What is NDC17478-0040-01?

NDC17478-0040-01 is a Lorazepam Injection manufactured by Akorn Inc.

What are the specifications of NDC17478-0040-01?

Please contact us for detailed specifications of NDC17478-0040-01.

Is NDC17478-0040-01 available for immediate shipping?

Yes, we ship worldwide with same-day handling on many parts depending on stock availability.

Can Aerospace Orbit supply bulk quantities of NDC17478-0040-01?

Yes, we support both small and large volume orders depending on stock.

Obtain a Quote for Akorn Inc Part Number NDC17478-0040-01 Now

Name: Part Number NDC17478-0040-01 - Lorazepam Injection
Brand: Akorn Inc
SKU: ndc17478-0040-01
Availability: InStock
Rating: 4.6 (226 reviews)

Part Number: NDC17478-0040-01

Alternate P/N: NDC17478004001

Manufacturer: Akorn Inc

NSN: 6505-01-650-2681

NIIN: 01-650-2681

Item Name : lorazepam injection

CAGE Code: 55751

INC Code : 50832

Country: USA

NCB Code: 01

When you would like to secure affordable procurement options for Akorn Inc part number NDC17478-0040-01, do not hesitate to take advantage of the Request for Quote (RFQ) form on this page. As you complete this form, be sure to offer us important details like your target price and expected fulfillment timeframe, as well as information for contacting you with our response. Within 15 minutes of receiving and reviewing your submission, a member of our staff will reach out to you to present a tailored solution on Akorn Inc part number NDC17478-0040-01 for your comparisons.

Do You Have Specific Questions About Particular Needs?

If you are managing a project that involves an extensive part list, urgent delivery timelines, or other specialized fulfillment requirements, our specialists will be glad to discuss your needs together. By contacting us by phone or email, you can connect with an experienced representative who will review your specifications in detail and present tailored solutions that align with your project goals, so never hesitate to reach out.

Note : We Will Not Share Your Information To Any Third Parties.

Please fill out below form for NDC17478-0040-01

Contact Information

“*” Required Fields Are Compulsory

* By clicking this box, I acknowledge that I have read and accept the ASAP Semiconductor Terms and Conditions and agree that all quotes and purchase orders are exclusively subject to the ASAP Semiconductor Terms and Conditions.

I consent to receive email communications from ASAP Semiconductor and can unsubscribe at any time.
ASAP Semiconductor is a wholly independent aftermarket parts distributor.
This website is intended for quotations based on part numbers only. Please DO NOT submit drawings, technical data, or other specifications through this portal.

Disclaimer: This is a quotation for the goods listed above. This quotation is meant as an estimate and does not reflect a final bill or invoice. All quotations are subject to change until acceptance by ASAP Semiconductor of a binding Purchase Order, and quotations may be withdrawn or revised at the sole discretion of ASAP Semiconductor. This quotation is subject to the ASAP Semiconductor Terms & Conditions available at https://www.asapsemi.com/customer-terms-and-conditions/ . All United States Government and Department of Defense bids are quoted as CAGE code 6RE77 from ASAP Semiconductor’s Anaheim, California facility. Any quotation from ASAP Semiconductor without 6RE77 is void.

If You Have Multiple Parts Requirement,
You Can Upload Your Parts List or BOM Here!

Upload

NSN Information for Part Number NDC17478-0040-01 with NSN 6505-01-650-2681, 6505016502681

NSN	FSC	NIIN	CLS	Hazmat	DEMIL	Cancelled NSN
6505-01-650-2681 Item PartTypeName: LORAZEPAM INJECTION	6505	016502681	M	P
	CIIC	HCC	ESD	PMIC	Criticality	ENAC
	Q			A	0
Part Number	ISC	RNVC	RNCC	HCC	MSDS	SADC
1389508	5	1	5

Characteristics Data of NSN 6505-01-650-2681, 6505016502681

MRC	Criteria	Characteristic
AJCN	PROTECTIVE STORAGE FEATURE	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
CSCW	TOTAL PRIMARY CONTAINER QUANTITY	10
AKJQ	PHARMACEUTICAL VEHICLE TYPE	AQUEOUS
CRLK	PRIMARY CONTAINER CONTENT QUANTITY	2.0 MILLILITERS
AKJA	ACTIVE MEDICAMENT MEDICINAL STRENGTH	2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM
CQCT	PRIMARY CONTAINER TYPE	VIAL
CRYC	CONTROLLED SUBSTANCE CLASSIFICATION	SCHEDULE IV
CSGS	ADMINISTRATION	INTRAVENOUS AND INTRAMUSCULAR
CXCY	PART NAME ASSIGNED BY CONTROLLING AGENCY	ATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE
FEAT	SPECIAL FEATURES	LORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG